个人中心 - 老虎社区

锦龙

IP属地：广东

帖子 · 2帖子 · 2
关注 · 0关注 · 0
粉丝 · 0粉丝 · 0

- 锦龙锦龙
  ·02-07
  $励晶太平洋(00575)$ 国家级专精特新“小巨人”康诺生物冲刺港股！以线粒体医学为核心，搭建“检测-干预-再检测”完整闭环，核心产品占营收半壁江山，两款管线进入临床二期，叠加抗衰赛道高景气，成长逻辑清晰可落地 $励晶太平洋(00575)$ $石药集团(01093)$
  85 评论
  1
  分享
  举报
- 锦龙锦龙
  ·02-06
  $励晶太平洋(00575)$ 数据说话：2024-2035年抗衰行业增速近20%，远超医疗健康大盘！随着技术落地，从前端检测到后端干预，全链条都有爆发机会$励晶太平洋(00575)$ $海吉亚医疗(06078)$
  110 评论
  1
  分享
  举报

热议股票

{"i18n":{"language":"zh_CN"},"isCurrentUser":false,"userPageInfo":{"id":"4233471011907460","uuid":"4233471011907460","gmtCreate":1770367791996,"gmtModify":1770369599098,"name":"锦龙","pinyin":"jljinlong","introduction":"","introductionEn":null,"signature":"","avatar":"https://static.tigerbbs.com/default-avatar2.jpg","hat":null,"hatId":null,"hatName":null,"vip":1,"status":2,"fanSize":0,"headSize":0,"tweetSize":2,"questionSize":0,"limitLevel":999,"accountStatus":1,"level":{"id":0,"name":"","nameTw":"","represent":"","factor":"","iconColor":"","bgColor":""},"themeCounts":0,"badgeCounts":0,"badges":[],"moderator":false,"superModerator":false,"manageSymbols":null,"badgeLevel":null,"boolIsFan":false,"boolIsHead":false,"favoriteSize":0,"symbols":null,"coverImage":null,"realNameVerified":"success","userBadges":[],"userBadgeCount":0,"currentWearingBadge":null,"individualDisplayBadges":null,"crmLevel":1,"crmLevelSwitch":0,"location":"广东","starInvestorFollowerNum":0,"starInvestorFlag":false,"starInvestorOrderShareNum":0,"subscribeStarInvestorNum":0,"ror":null,"winRationPercentage":null,"showRor":false,"investmentPhilosophy":null,"starInvestorSubscribeFlag":false},"page":1,"watchlist":null,"tweetList":[{"id":530205880874448,"gmtCreate":1770465691083,"gmtModify":1770468806030,"author":{"id":"4233471011907460","authorId":"4233471011907460","name":"锦龙","avatar":"https://static.tigerbbs.com/default-avatar2.jpg","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4233471011907460","idStr":"4233471011907460"},"themes":[],"title":"","htmlText":"<a href=\"https://laohu8.com/S/00575\">$励晶太平洋(00575)$ </a> 国家级专精特新“小巨人”康诺生物冲刺港股！以线粒体医学为核心，搭建“检测-干预-再检测”完整闭环，核心产品占营收半壁江山，两款管线进入临床二期，叠加抗衰赛道高景气，成长逻辑清晰可落地 <a href=\"https://laohu8.com/S/00575\">$励晶太平洋(00575)$ </a>&nbsp;<a href=\"https://laohu8.com/S/01093\">$石药集团(01093)$&nbsp;</a>&nbsp;","listText":"<a href=\"https://laohu8.com/S/00575\">$励晶太平洋(00575)$ </a> 国家级专精特新“小巨人”康诺生物冲刺港股！以线粒体医学为核心，搭建“检测-干预-再检测”完整闭环，核心产品占营收半壁江山，两款管线进入临床二期，叠加抗衰赛道高景气，成长逻辑清晰可落地 <a href=\"https://laohu8.com/S/00575\">$励晶太平洋(00575)$ </a>&nbsp;<a href=\"https://laohu8.com/S/01093\">$石药集团(01093)$&nbsp;</a>&nbsp;","text":"$励晶太平洋(00575)$ 国家级专精特新“小巨人”康诺生物冲刺港股！以线粒体医学为核心，搭建“检测-干预-再检测”完整闭环，核心产品占营收半壁江山，两款管线进入临床二期，叠加抗衰赛道高景气，成长逻辑清晰可落地 $励晶太平洋(00575)$ $石药集团(01093)$","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/530205880874448","isVote":1,"tweetType":1,"viewCount":85,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":529812435398808,"gmtCreate":1770369708475,"gmtModify":1770370943264,"author":{"id":"4233471011907460","authorId":"4233471011907460","name":"锦龙","avatar":"https://static.tigerbbs.com/default-avatar2.jpg","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4233471011907460","idStr":"4233471011907460"},"themes":[],"title":"","htmlText":"<a href=\"https://laohu8.com/S/00575\">$励晶太平洋(00575)$ </a> 数据说话：2024-2035年抗衰行业增速近20%，远超医疗健康大盘！随着技术落地，从前端检测到后端干预，全链条都有爆发机会<a href=\"https://laohu8.com/S/00575\">$励晶太平洋(00575)$ </a><a href=\"https://laohu8.com/S/06078\">$海吉亚医疗(06078)$ </a>&nbsp;","listText":"<a href=\"https://laohu8.com/S/00575\">$励晶太平洋(00575)$ </a> 数据说话：2024-2035年抗衰行业增速近20%，远超医疗健康大盘！随着技术落地，从前端检测到后端干预，全链条都有爆发机会<a href=\"https://laohu8.com/S/00575\">$励晶太平洋(00575)$ </a><a href=\"https://laohu8.com/S/06078\">$海吉亚医疗(06078)$ </a>&nbsp;","text":"$励晶太平洋(00575)$ 数据说话：2024-2035年抗衰行业增速近20%，远超医疗健康大盘！随着技术落地，从前端检测到后端干预，全链条都有爆发机会$励晶太平洋(00575)$ $海吉亚医疗(06078)$","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/529812435398808","isVote":1,"tweetType":1,"viewCount":110,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0}],"defaultTab":"posts","isTTM":false}